We are live on ! Find out more
KALV

KalVista Pharmaceuticals

Delisted

KALV was delisted on the 10th of June, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$21.9M -$278K -22,243 -1%
SHI
2
SV Health Investors
Massachusetts
$21.6M
EAM
3
Eventide Asset Management
Massachusetts
$21.2M
VC
4
Vivo Capital
California
$18.6M
IC
5
Ikarian Capital
Texas
$15.6M +$1.53M +122,076 +11%
BlackRock
6
BlackRock
New York
$11.5M -$114K -9,117 -1%
PAMU
7
Pictet Asset Management (UK)
United Kingdom
$10.7M +$349K +27,878 +3%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$9.62M +$7.01M +561,000 +276%
Vanguard Group
9
Vanguard Group
Pennsylvania
$7.04M -$5.99K -479 -0.1%
OM
10
Opaleye Management
Massachusetts
$5.86M +$109K +8,703 +2%
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$5.04M
IVM
12
InterWest Venture Management
California
$4.89M
GTC
13
Ghost Tree Capital
New York
$4.41M
SCM
14
Suvretta Capital Management
New York
$3.89M +$774K +61,900 +25%
LGM
15
Logos Global Management
California
$3.78M -$3.29M -262,900 -47%
State Street
16
State Street
Massachusetts
$3.28M +$110K +8,795 +3%
SFM
17
Sphera Funds Management
Israel
$3.02M
Northern Trust
18
Northern Trust
Illinois
$3.01M -$41.2K -3,297 -1%
Franklin Resources
19
Franklin Resources
California
$2.94M
DCM
20
DAFNA Capital Management
California
$2.62M -$180K -14,398 -6%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$2.62M +$120K +9,592 +5%
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$2.47M +$25K +2,000 +1%
IBT
23
International Biotechnology Trust
United Kingdom
$2.23M
Janus Henderson Group
24
Janus Henderson Group
$2.13M +$103K +8,233 +5%
BFM
25
Boothbay Fund Management
New York
$1.66M +$86.5K +6,920 +6%